OBJECTIVE: To describe the epidemiology of neonatal abstinence syndrome (NAS) in a 16-county Appalachian area of eastern Tennessee. METHODS: The Tennessee Surveillance System for NAS provided data on maternal sources of opioids. Data linking hospital discharge diagnosis for NAS to birth certificate data allowed us to compare maternal, delivery, and infant characteristics for NAS births with those for non-NAS births. RESULTS: There were 339 cases of NAS in 2013 and 367 in 2014, for NAS rates of 25.5 and 28.5 per 1,000 live births, respectively. When compared with the state overall, mothers of NAS infants in eastern Tennessee were more likely to use opioids that had been prescribed to another person. There were numerous maternal, infant, and delivery characteristics that were significantly different for NAS births compared with non-NAS births. CONCLUSION: Neonatal abstinence syndrome is epidemic in the eastern Tennessee area of Appalachia, with unique maternal and infant characteristics that have important implications for primary, secondary, and tertiary prevention.
OBJECTIVE: To describe the epidemiology of neonatal abstinence syndrome (NAS) in a 16-county Appalachian area of eastern Tennessee. METHODS: The Tennessee Surveillance System for NAS provided data on maternal sources of opioids. Data linking hospital discharge diagnosis for NAS to birth certificate data allowed us to compare maternal, delivery, and infant characteristics for NAS births with those for non-NAS births. RESULTS: There were 339 cases of NAS in 2013 and 367 in 2014, for NAS rates of 25.5 and 28.5 per 1,000 live births, respectively. When compared with the state overall, mothers of NAS infants in eastern Tennessee were more likely to use opioids that had been prescribed to another person. There were numerous maternal, infant, and delivery characteristics that were significantly different for NAS births compared with non-NAS births. CONCLUSION:Neonatal abstinence syndrome is epidemic in the eastern Tennessee area of Appalachia, with unique maternal and infant characteristics that have important implications for primary, secondary, and tertiary prevention.
Authors: Jennifer R Havens; Jeffrey C Talbert; Robert Walker; Cynthia Leedham; Carl G Leukefeld Journal: J Rural Health Date: 2006 Impact factor: 4.333
Authors: Meagan E Stabler; D Leann Long; Ilana R A Chertok; Peter R Giacobbi; Courtney Pilkerton; Laura R Lander Journal: J Rural Health Date: 2016-02-16 Impact factor: 4.333
Authors: Jennifer N Lind; Emily E Petersen; Philip A Lederer; Ghasi S Phillips-Bell; Cria G Perrine; Ruowei Li; Mark Hudak; Jane A Correia; Andreea A Creanga; William M Sappenfield; John Curran; Carina Blackmore; Sharon M Watkins; Suzanne Anjohrin Journal: MMWR Morb Mortal Wkly Rep Date: 2015-03-06 Impact factor: 17.586
Authors: Michael D Warren; Angela M Miller; Julie Traylor; Audrey Bauer; Stephen W Patrick Journal: MMWR Morb Mortal Wkly Rep Date: 2015-02-13 Impact factor: 17.586
Authors: Christine A Schalkoff; Kathryn E Lancaster; Bradley N Gaynes; Vivian Wang; Brian W Pence; William C Miller; Vivian F Go Journal: Subst Abus Date: 2019-08-12 Impact factor: 3.716
Authors: Julia Brennan; Caleb Wiedeman; John R Dunn; William Schaffner; Timothy F Jones Journal: Public Health Rep Date: 2019-08-07 Impact factor: 2.792
Authors: Karina Beltrán-Arzate; Kevin Hodson; Haley K Tes; Sarah-Anne H Bowyer; Hollis C Ratliff; Michael M Abraham; Elizabeth Johnson; Malinda Harris; Julia Jaekel Journal: Womens Health (Lond) Date: 2021 Jan-Dec